Roxithromycin (RU 965): effective therapy for experimental syphilis infection in rabbits
- PMID: 3551828
- PMCID: PMC174689
- DOI: 10.1128/AAC.31.2.187
Roxithromycin (RU 965): effective therapy for experimental syphilis infection in rabbits
Abstract
Roxithromycin (RU 965), a new macrolide antibiotic, was shown to be effective for therapy of active syphilis in rabbits. Dark-field-positive lesions were produced in adult male rabbits by intradermal inoculation of approximately 10(6) Treponema pallidum organisms at each of 11 sites. Beginning 7 days after infection, six animals per group were treated with benzathine penicillin G (200,000 U, intramuscularly, weekly for 2 weeks) or roxithromycin (15 mg/kg of body weight, orally, twice daily for 15 days); six animals were not treated. Chancres in untreated animals were dark-field positive throughout the 16-day observation period; all benzathine penicillin-treated rabbits were dark-field negative 1 day after the initiation of therapy. Five of six animals treated with roxithromycin were dark-field negative on day 3 following the initiation of therapy; the sixth animal was dark-field negative by day 6. Lesions in untreated animals reached a mean (+/- standard deviation) maximum diameter of 14.7 +/- 1.91 mm compared with 8.4 +/- 3.6 mm for benzathine penicillin-treated (P less than 0.005) and 10.4 +/- 1.2 mm for roxithromycin-treated (P less than 0.001) animals. Ulceration occurred at 62 of 66 lesions in untreated animals compared with 0 of 66 lesions in each treated group. At 3, 6, and 12 weeks postinfection, Venereal Disease Research Laboratory antibody titers were significantly higher (P less than 0.05) in untreated than in treated animals. Titers in penicillin-treated versus roxithromycin-treated animals were significantly different at 6 weeks postinfection but not at 3 and 12 weeks postinfection. Transfer of tissue from treated rabbits to seronegative recipient animals did not reveal any evidence of persistent infection in the benzathine penicillin- or roxithromycin-treated animals. These findings indicate that benzathine penicillin and roxithromycin, at the doses indicated above, are effective in treating active syphilis in rabbit model.
Similar articles
-
Efficacy of cefmetazole in the treatment of active syphilis in the rabbit model.Antimicrob Agents Chemother. 1989 Sep;33(9):1465-9. doi: 10.1128/AAC.33.9.1465. Antimicrob Agents Chemother. 1989. PMID: 2684008 Free PMC article.
-
Efficacy of azithromycin for therapy of active syphilis in the rabbit model.J Antimicrob Chemother. 1990 Jan;25 Suppl A:91-9. doi: 10.1093/jac/25.suppl_a.91. J Antimicrob Chemother. 1990. PMID: 2154443
-
Evaluation of rosaramicin phosphate in treatment of experimental syphilis in rabbits.Antimicrob Agents Chemother. 1981 Jan;19(1):117-21. doi: 10.1128/AAC.19.1.117. Antimicrob Agents Chemother. 1981. PMID: 7018381 Free PMC article.
-
Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature.Arch Dermatol. 2001 Oct;137(10):1374-6. Arch Dermatol. 2001. PMID: 11594871 Review. No abstract available.
-
Syphilis--diagnosis and treatment.Clin Obstet Gynecol. 1975 Mar;18(1):163-82. doi: 10.1097/00003081-197503000-00015. Clin Obstet Gynecol. 1975. PMID: 1091382 Review. No abstract available.
Cited by
-
Efficacy of cefmetazole in the treatment of active syphilis in the rabbit model.Antimicrob Agents Chemother. 1989 Sep;33(9):1465-9. doi: 10.1128/AAC.33.9.1465. Antimicrob Agents Chemother. 1989. PMID: 2684008 Free PMC article.
-
Rabbit Models for Studying Human Infectious Diseases.Comp Med. 2015 Dec;65(6):499-507. Comp Med. 2015. PMID: 26678367 Free PMC article. Review.
-
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.Drugs. 1989 Jan;37(1):8-41. doi: 10.2165/00003495-198937010-00002. Drugs. 1989. PMID: 2651088 Review.
-
Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.Drugs. 1994 Aug;48(2):297-326. doi: 10.2165/00003495-199448020-00011. Drugs. 1994. PMID: 7527329 Review.
-
Clarithromycin therapy of experimental Treponema pallidum infections in hamsters.Antimicrob Agents Chemother. 1993 Apr;37(4):864-7. doi: 10.1128/AAC.37.4.864. Antimicrob Agents Chemother. 1993. PMID: 8494384 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical